Zobrazeno 1 - 10
of 26
pro vyhledávání: '"George Simeakis"'
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2021)
Medullary thyroid carcinoma (MTC) has a varying clinical course; distant metastases are frequently present even at diagnosis. We present two MTC cases with unusual metastatic sites. Two female patients are presented with slow progressive MTC. The fir
Externí odkaz:
https://doaj.org/article/4eb128451f39437d88fb962f2eba9149
Autor:
George Simeakis, Maria Anagnostouli, Nikolaos Fakas, John Koutsikos, Athanasios Papatheodorou, Konstantinos Chanopoulos, Kwnstantinos Athanasiou, George Papatheodorou, Evangelia Zapanti, Maria Alevizaki, Gregory Kaltsas, Evangelos Terpos
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 603 (2023)
High-dose intravenous steroid treatment (HDIST) represents the first choice of treatment for multiple sclerosis (MS) relapses. Chronic oral glucocorticoid (GC) administration correlates with bone loss whereas data regarding HDIST in MS are still conf
Externí odkaz:
https://doaj.org/article/89cd6cc51fb04fc8b525bc043f168d67
Autor:
Nikolaos Markoglou, George Simeakis, Maria Alevizaki, Georgios Velonakis, Theofanis Chatzistamatiou, Maria Spyropoulou-Vlachou, Catherine Stavropoulos-Giokas, Leonidas Stefanis, Maria Anagnostouli
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2850 (2022)
Multiple sclerosis (MS) and its various comorbidities that may be observed are of great interest due to the complexity of MS pathophysiology and all of the immunological changes that follow. The incidence of cancer in MS has been investigated for sev
Externí odkaz:
https://doaj.org/article/2e5e09128a1d4eaf8120d6cd3c39793b
Autor:
Katerina Saltiki, Elli Anagnostou, George Simeakis, Sofia Kouki, Anastasia Angelopoulou, Leda Sarika, Alexandra Papathoma, Maria Alevizaki
Publikováno v:
Endocrine Connections, Vol 6, Iss 8, Pp 676-684 (2017)
Introduction: High prevalence of RET p.Gly533Cys (c.1597G > T) has been found in familial MTC in Greece (exon 8 fMTC). We studied their origin and compared clinical characteristics with non-exon 8 fMTC. Methods: 102 fMTC (FMTC and MEN2A) patients (3
Externí odkaz:
https://doaj.org/article/bc02a0d58b824628a4b906a9f01bd834
Publikováno v:
Endocrine. 80:570-579
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f29a08cf2c039717b089082799bcdb4
https://doi.org/10.1007/s12020-022-03296-1
https://doi.org/10.1007/s12020-022-03296-1
Publikováno v:
Endocrine-Related Cancer. 29:R57-R66
During the last decades, the knowledge on follicular cell-derived thyroid cancer molecular biology has led to the evolution of a number of novel therapies for these tumors, mainly tyrosine kinase inhibitors. Lenvantinib, sorafenib and recently caboza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc21833377f4cfe403385f39bc151742
https://doi.org/10.1530/erc-22-0006
https://doi.org/10.1530/erc-22-0006
Autor:
George Simeakis, Cristina Romei, Raffaele Ciampi, Teresa Ramone, Katerina Saltiki, Rossella Elisei, Maria Alevizaki
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97e64244a7fe65b38f782995880c8a53
https://doi.org/10.1530/endoabs.84.op-09-43
https://doi.org/10.1530/endoabs.84.op-09-43
Autor:
Barbara Vlassopoulou, Efi Botoula, Olga Karapanou, George Simeakis, Stylianos Tsagarakis, Maria Alevizaki, Katerina Saltiki
Publikováno v:
Clinical Endocrinology. 95:217-223
CONTEXT Anti-thyroglobulin antibodies (anti-Tg), present in 20%-25% of differentiated thyroid cancer (DTC) patients, interfere with thyroglobulin measurements posing a challenge in the follow-up. OBJECTIVES The aim of this study was to identify clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a75aed76c367959fa9dbe5e0e3e795
https://doi.org/10.1111/cen.14456
https://doi.org/10.1111/cen.14456
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f34d3dd69ad7ecbc86f683ce93d41bb6
https://doi.org/10.1530/endoabs.81.p732
https://doi.org/10.1530/endoabs.81.p732
Publikováno v:
European journal of endocrinology. 187(3)
During the last decades, knowledge of the molecular biology in medullary thyroid carcinoma (MTC) and specifically on the role of rearranged during transfection (RET)-activating mutations in tumorigenesis has led to the evolution of novel targeted the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bfc3e37020910056166e50ce2c0dc00
https://pubmed.ncbi.nlm.nih.gov/35895692
https://pubmed.ncbi.nlm.nih.gov/35895692